These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 31493764)

  • 21. Prognostic value of immune-related genes in clear cell renal cell carcinoma.
    Wan B; Liu B; Huang Y; Yu G; Lv C
    Aging (Albany NY); 2019 Dec; 11(23):11474-11489. PubMed ID: 31821170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
    Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
    Front Immunol; 2022; 13():861328. PubMed ID: 35479084
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y
    Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
    Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
    Front Immunol; 2022; 13():890150. PubMed ID: 35686121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
    Theodros D; Murter BM; Sidhom JW; Nirschl TR; Clark DJ; Chen L; Tam AJ; Blosser RL; Schwen ZR; Johnson MH; Pierorazio PM; Zhang H; Ganguly S; Pardoll DM; Zarif JC
    Mol Cell Proteomics; 2020 Nov; 19(11):1850-1859. PubMed ID: 32737216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
    Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
    FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
    Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
    Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.
    Ge YZ; Wu R; Xin H; Zhu M; Lu TZ; Liu H; Xu Z; Yu P; Zhao YC; Li MH; Hu ZK; Zhao Y; Zhong B; Xu X; Zhou LH; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1291-9. PubMed ID: 25633718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
    Lu X; Wan F; Zhang H; Shi G; Ye D
    Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
    Oxid Med Cell Longev; 2021; 2021():6648093. PubMed ID: 33968297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A signature based on chromatin regulation and tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Yang C; Yu T; Lin Q
    Epigenomics; 2022 Sep; 14(17):995-1013. PubMed ID: 36154213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
    Dong X; Gu DN; Wang O; Ye Z
    Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.